LIFR and hepatocellular carcinoma: A number of previous studies reported that miR-221-3p was up-regulated in 70-80% of HCC cases, and exerted its role on HCC cell viability and motility via targeting the leukemia inhibitory factor receptor (LIFR) (22–24).